Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY: GMED )

83.79 +0.32 (+0.38%)
Streaming Delayed Price Updated: 12:44 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 80,188
Open 83.07
Bid (Size) 83.65 (1)
Ask (Size) 83.80 (2)
Prev. Close 83.47
Today's Range 83.07 - 84.01
52wk Range 49.33 - 87.22
Shares Outstanding 136,167,342
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
16 Analysts Have This To Say About Globus Medical
Via Benzinga
Inari Medical Stock Gets RS Rating Upgrade
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily

Performance

YTD
+57.62%
+57.62%
1 Month
-0.83%
-0.83%
3 Month
+19.10%
+19.10%
6 Month
+23.11%
+23.11%
1 Year
+54.91%
+54.91%

More News

Read More
Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing?
Via Chartmill
Novocure Stock Earns 96 RS Rating
Via Investor's Business Daily
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
Evaluating Globus Medical: Insights From 11 Financial Analysts
Via Benzinga
What 7 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts
Via Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
Via Chartmill
Globus Medical Launches ExcelsiusHub™ Navigation System
From Globus Medical
Via GlobeNewswire
Despite its growth, NYSE:GMED remains within the realm of affordability.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Looking Into Globus Medical's Recent Short Interest
Via Benzinga
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts
Via Benzinga
Globus Medical Reports Third Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
From Globus Medical
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
Via Chartmill
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino’s and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.